Cargando…
A novel soluble epoxide hydrolase vaccine protects murine cardiac muscle against myocardial infarction
Myocardial infarction is still a life-threatening disease, even though its prognosis has been improved through the development of percutaneous coronary intervention and pharmacotherapy. In addition, heart failure due to remodeling after myocardial infarction requires lifelong management. The aim of...
Autores principales: | Kitsuka, Takahiro, Shiraki, Aya, Oyama, Jun-ichi, Nakagami, Hironori, Tanaka, Atsushi, Node, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051153/ https://www.ncbi.nlm.nih.gov/pubmed/35484372 http://dx.doi.org/10.1038/s41598-022-10641-x |
Ejemplares similares
-
Author Correction: A novel soluble epoxide hydrolase vaccine protects murine cardiac muscle against myocardial infarction
por: Kitsuka, Takahiro, et al.
Publicado: (2022) -
Deletion of Apoptosis Inhibitor of Macrophage (AIM)/CD5L Attenuates the Inflammatory Response and Infarct Size in Acute Myocardial Infarction
por: Nishikido, Toshiyuki, et al.
Publicado: (2016) -
Soluble Epoxide Hydrolase in Atherosclerosis
por: Wang, Yi-Xin Jim, et al.
Publicado: (2010) -
COA-Cl (2-Cl-C.OXT-A) can promote coronary collateral development following acute myocardial infarction in mice
por: Nishikido, Toshiyuki, et al.
Publicado: (2019) -
Decreased Expression of Soluble Epoxide Hydrolase Suppresses Murine Choroidal Neovascularization
por: Park, Bomina, et al.
Publicado: (2022)